Downloads: 0 | Views: 114
Informative Article | Mechanics Science | India | Volume 10 Issue 12, December 2021 | Popularity: 4.6 / 10
Optimizing Oncology Commercialization: A Comparative Analysis of Pre- and Post- Launch Metrics
Nazim N Haider
Abstract: Commercial success in oncology is crucial for driving innovation, ensuring patient access to cutting-edge treatments, and sustaining research and development efforts in the fight against cancer. This paper explores a comparative analysis of pre- and post-launch metrics in oncology, highlighting the importance of addressing market dynamics, access barriers, and competitive positioning for successful commercialization. Challenges faced by oncology therapies with high clinical success but poor commercial success, such as talimogene laherparepvec (T-VEC), are examined to illustrate the complexities of the oncology market. The use of real-world data sources, including electronic health records, patient registries, and claims data, is discussed in evaluating commercial metrics and optimizing strategies for oncology products. By understanding and leveraging pre- and post-launch metrics, pharmaceutical companies and healthcare providers can navigate the complexities of the oncology market, drive sustainable growth, and enhance patient outcomes.
Keywords: commercialization, pre-launch metrics, post-launch metrics, competitive positioning, patient access, market share, key opinion leaders, patient outcomes
Edition: Volume 10 Issue 12, December 2021
Pages: 1513 - 1516
DOI: https://www.doi.org/10.21275/SR24709205841
Make Sure to Disable the Pop-Up Blocker of Web Browser